If your child needs a stronger prescription year after year, you are not alone, and acting on it is exactly the right instinct. The faster a child's nearsightedness progresses, the higher their lifetime risk of serious eye problems like retinal detachment and glaucoma, which is why slowing it matters. Mudgil Eye Associates offers myopia control for Paoli families about 20 minutes away via Route 30 (Lancaster Avenue), with both FDA-approved MiSight contact lenses and low-dose atropine, guided by a Johns Hopkins fellowship-trained pediatric ophthalmologist and a residency-trained pediatric optometrist. We are a complete MD-and-OD team, not an optometry-only office, so if anything beyond myopia ever comes up, expert care is already in place.
MiSight is an FDA-approved daily contact lens proven to slow the progression of myopia in children. Your child wears it during the day, and it both corrects vision and helps keep the prescription from climbing as quickly. We are listed on the manufacturer's official provider locator.
Dr. A. Vijay Mudgil completed his pediatric ophthalmology fellowship at the Wilmer Eye Institute, Johns Hopkins, and our optometrist provides residency-trained pediatric care. Your child's myopia plan is overseen by genuine pediatric eye specialists, not a general optical shop.
For children who are not ready for contact lenses, we also offer low-dose atropine eye drops, a simple nightly drop widely used to help slow myopia progression. We help you choose the approach that fits your child best, and some children do well with a combination.
Unlike a standalone optometry office, we are a complete MD-and-OD practice. A fellowship-trained pediatric ophthalmologist works alongside our optometrist, so if your child ever needs more than myopia control, surgical-level expertise is already part of their care.
A pattern many Paoli parents recognize is that they were nearsighted as children too, and now they are watching the same thing unfold in their own kids. Family history is one of the strongest predictors of childhood myopia, and parents who wore glasses early are often the most motivated to do things differently for the next generation. Our West Chester office is a short drive away, and a family history of myopia is one of the most common reasons families seek us out.
Myopia tends to run in families. A child with one nearsighted parent has a higher likelihood of becoming myopic, and that likelihood rises further when both parents are nearsighted. Genetics influences how the eye grows and how prone it is to elongating during childhood. It does not seal a child's fate, but it does raise the odds and often the pace, which is why family history is a signal to watch a child's eyes closely from an early age.
Inherited tendency is only part of the story. The same near-work habits and limited outdoor time that influence any child's eyes can amplify a genetic predisposition. A child who inherits a higher baseline risk and also spends long hours on close-up tasks with little time outdoors may progress faster than genetics alone would predict. This is encouraging in a way, because while we cannot change a child's genes, we can influence the environmental factors and add medical treatment.
When myopia runs in the family, we encourage earlier and more attentive monitoring. Establishing a baseline prescription and tracking it lets us catch progression as soon as it accelerates, rather than after a large jump. For families where both parents needed glasses young, this watchfulness can make a real difference in starting a control plan at the right moment instead of playing catch-up.
Genetic risk does not change which tools we use, but it can change how proactively we use them. The options include MiSight 1 day contact lenses, FDA-approved to slow progression in children around ages 8 to 12; low-dose atropine drops, commonly 0.01% to 0.05% and used off-label; and orthokeratology overnight lenses. Dr. Mudgil, a board-certified ophthalmologist with Johns Hopkins/Wilmer fellowship training, and our optometrist tailor the approach to the child. Acting matters because higher myopia is associated with greater lifetime risk of retinal detachment, glaucoma, and myopic maculopathy, and predisposed children can reach those higher levels if progression goes unchecked.
The risk is higher with two nearsighted parents, but it is a probability, not a certainty.
Yes. We cannot change genes, but we can influence environment and slow progression with treatment.
We generally recommend earlier, closer monitoring for children with a strong family history.
It does not change the options, but it may lead us to act more proactively.
Most Paoli families are seen within one to two weeks for an initial myopia evaluation. Call 610-429-3004 or schedule online, and we will help you get ahead of your child's nearsightedness.